Research ArticleClinical Studies
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease
DAICHI FUJIMOTO, RYOKO SHIMIZU, RYOJI KATO, YUKI SATO, MARIKO KOGO, JIRO ITO, SHUNSUKE TERAOKA, TAKEHIRO OTOSHI, KAZUMA NAGATA, ATSUSHI NAKAGAWA, KOJIRO OTSUKA, NOBUYUKI KATAKAMI and KEISUKE TOMII
Anticancer Research November 2015, 35 (11) 6261-6266;
DAICHI FUJIMOTO
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
RYOKO SHIMIZU
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
RYOJI KATO
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
YUKI SATO
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
MARIKO KOGO
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
JIRO ITO
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
SHUNSUKE TERAOKA
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
TAKEHIRO OTOSHI
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
KAZUMA NAGATA
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
ATSUSHI NAKAGAWA
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
KOJIRO OTSUKA
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
NOBUYUKI KATAKAMI
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
KEISUKE TOMII
Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
In this issue
Anticancer Research
Vol. 35, Issue 11
November 2015
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease
DAICHI FUJIMOTO, RYOKO SHIMIZU, RYOJI KATO, YUKI SATO, MARIKO KOGO, JIRO ITO, SHUNSUKE TERAOKA, TAKEHIRO OTOSHI, KAZUMA NAGATA, ATSUSHI NAKAGAWA, KOJIRO OTSUKA, NOBUYUKI KATAKAMI, KEISUKE TOMII
Anticancer Research Nov 2015, 35 (11) 6261-6266;
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease
DAICHI FUJIMOTO, RYOKO SHIMIZU, RYOJI KATO, YUKI SATO, MARIKO KOGO, JIRO ITO, SHUNSUKE TERAOKA, TAKEHIRO OTOSHI, KAZUMA NAGATA, ATSUSHI NAKAGAWA, KOJIRO OTSUKA, NOBUYUKI KATAKAMI, KEISUKE TOMII
Anticancer Research Nov 2015, 35 (11) 6261-6266;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
- Nab-paclitaxel Monotherapy for Relapsed Small Cell Lung Cancer: Retrospective Analysis and Review
- Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms
- Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer
- Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer